XORTX Therapeutics Inc.
XRTX.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.31M | -736.60K | -1.48M | -3.35M | -2.16M |
| Total Depreciation and Amortization | 117.10K | 115.40K | 106.00K | 105.00K | 139.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -599.40K | -3.45M | -3.17M | -1.55M | -3.53M |
| Change in Net Operating Assets | 116.80K | -23.20K | 142.30K | -612.40K | -1.03M |
| Cash from Operations | -3.68M | -4.09M | -4.41M | -5.40M | -6.58M |
| Capital Expenditure | -- | 0.00 | 0.00 | -1.60K | -4.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -38.90K | -44.70K | -28.80K | -27.60K | -42.10K |
| Cash from Investing | -38.90K | -44.70K | -28.80K | -29.20K | -46.30K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -69.70K | -64.00K | -58.50K | -66.00K | -66.20K |
| Issuance of Common Stock | 3.52M | 2.02M | 2.02M | 2.02M | 300.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -667.90K | -592.90K | -592.90K | -586.70K | -295.30K |
| Cash from Financing | 2.78M | 1.36M | 1.37M | 1.36M | -361.10K |
| Foreign Exchange rate Adjustments | -36.00K | 6.20K | -13.50K | -6.40K | 4.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -974.00K | -2.77M | -3.09M | -4.07M | -6.99M |
